The significant EPS miss and declining gross margins are bearish signals. However, the affirmed guidance suggests management expects H2 2026 to be much stronger. Monitor Q2 2026 results for evidence of the promised recovery and any M&A announcements that could catalyze the stock.
Price Chart
Executive Summary
Kamada reported Q1 2026 EPS of $0.06, a 47.8% miss vs the $0.12 consensus, and revenue of $45.2M (+3% YoY) which was well below the $143.6M consensus (likely a mismatch in period — Q1 vs full-year). The company affirmed 2026 guidance of $200M-$205M revenue and $50M-$53M adjusted EBITDA, but the quarter was impacted by a temporary shipment delay. Net income was $4.1M, up 4% YoY.
Key Financial Metrics
Key Facts
- Q1 2026 EPS of $0.06 missed consensus of $0.12 by 47.8%
- Q1 2026 revenue of $45.2M, up 3% YoY from $44.0M
- Gross margin declined to 42% from 47% YoY due to product/market mix
- Adjusted EBITDA of $11.6M, flat YoY
- Company affirms 2026 guidance: $200M-$205M revenue, $50M-$53M adjusted EBITDA
- Net income of $4.1M, up 4% YoY from $4.0M
- Cash and equivalents of $32.9M, down from $75.5M at year-end 2025
- FDA approval for San Antonio plasma collection center received in February 2026
Financial Impact
EPS miss of 47.8% vs consensus; revenue 68.5% below consensus (likely period mismatch); gross margin down 500 bps YoY
Risk Factors
- Continued gross margin compression from product mix shift
- Failure to deliver on H2 2026 guidance after Q1 miss
- Cash burn from plasma center investments and dividend payments
- Execution risk on M&A and business development initiatives
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3293856 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | EFFECT | $8.19 $8.77 | ▲ +7.08% | ▲ +4.52% | $8.20 (+0.12%) |
Sep 10, 2026 22d ago | 6-K | $7.99 $8.67 | ▲ +8.51% | ▲ +9.01% | $8.20 (+2.63%) |
Sep 3, 2026 29d ago | Press Release | $8.54 $8.31 | ▼ −2.69% | ▼ −1.48% | $8.20 (−3.98%) |
Sep 3, 2026 29d ago | 6-K | $8.54 $8.31 | ▼ −2.69% | ▼ −1.48% | $8.20 (−3.98%) |
Aug 17, 2026 6w ago | 6-K / PRESS-RELEASE | $7.76 $8.43 | ▲ +8.63% | ▲ +9.82% | $8.20 (+5.67%) |
Aug 12, 2026 7w ago | 6-K | $6.88 $7.89 | ▲ +14.68% | ▲ +15.12% | $8.20 (+19.19%) |
Aug 5, 2026 8w ago | 6-K | $7.14 $7.26 | ▲ +1.68% | ▲ +0.47% | $8.20 (+14.85%) |
Aug 5, 2026 8w ago | 6-K | $7.18 $6.88 | ▼ −4.18% | ▼ −4.53% | $8.20 (+14.21%) |
Jul 20, 2026 10w ago | 6-K | $7.09 $7.06 | ▼ −0.42% | ▲ +0.00% | $8.20 (+15.66%) |
Jul 13, 2026 11w ago | 6-K | $7.17 $7.05 | ▼ −1.67% | ▼ −0.89% | $8.20 (+14.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access